Columvi Becomes Canada’s First Approved Bispecific Antibody for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBL)
This article gives a brief overview of Columvi (Glofitamab) and explains the basis for its approval for treating certain types of Diffuse Large B-cell lymphoma (DLBL), and patients may explore options to Buy Columvi online in India through regulated channels. Understanding Columvi (Glofitamab) Columvi therapy is used in the adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell lymphoma (LBCL) arising from follicular lymphoma, after two or more lines of systemic therapy, and treatment planning often includes understanding the Columvi price in India . Glofitamab is the antibody present in the Columvi that recognizes and attaches to CD20 (protein on the surface of B cells) and to CD3 (protein on the surface of healthy T cells), and many patients also search for options to Buy glofitamab online in India after consulting their doctor. When the Columvi acts as a bridge to unite both the proteins, it eventually kills t...